Ahmed Abdelshafy Tabl

Anti-vascular endothelial growth factor (anti-VEGF) therapy has become the standard of care for the management of retinal vascular diseases, including diabetic macular oedema (DMO), neovascular age-related macular degeneration (nAMD), retinal vein occlusion (RVO) and proliferative diabetic retinopathy (PDR), which remain major causes of vision loss worldwide [1].

Management of Preretinal Hemorrhage Due to Forceps Trauma During ILM Peeling Ahmed Abdelshafy Tabl, MD Show Description + Ahmed Abdelshafy Tabl, MD, presents a case of rhegmatogenous retinal detachment with subretinal proliferative vitreoretinopathy that was managed without subretinal bands removal. During silicone oil removal, the forceps hit the retina causing preretinal bleeding. This complication was managed and vision improved to 6/36.

The 'Light Pipe Trick' to Safely Perform Fluid-Air Exchange Ahmed Abdelshafy Tabl, MD; Amr Azab, MD; and Mahrous Shaheen, MD Show Description + In this surgery, Ahmed Abdelshafy Tabl, MD, shows a case of upper temporal bullous rhegmatogenous retinal detachment in a patient with one eye, with difficult subretinal fluid removal. Dr. Tabl demonstrates the 'light pipe trick' previously described by Amr Azab, MD, and Mahrous Shaheen, MD.